Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-103123
Filing Date
2025-08-05
Accepted
2025-08-05 16:30:55
Documents
53
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cycn-20250630.htm   iXBRL 10-Q 1550348
2 EX-10.1 cycn-ex10_1.htm EX-10.1 71598
3 EX-31.1 cycn-ex31_1.htm EX-31.1 13115
4 EX-31.2 cycn-ex31_2.htm EX-31.2 13118
5 EX-32.1 cycn-ex32_1.htm EX-32.1 7501
6 EX-32.2 cycn-ex32_2.htm EX-32.2 7504
  Complete submission text file 0000950170-25-103123.txt   5970262

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cycn-20250630.xsd EX-101.SCH 1039916
55 EXTRACTED XBRL INSTANCE DOCUMENT cycn-20250630_htm.xml XML 846392
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

EIN.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38787 | Film No.: 251185465
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)